Global Genome Engineering Market, 2018-2024 - Market to Grow with a CAGR of 11.80%

DUBLIN, June 22, 2018 /PRNewswire/ --

The "Genome Engineering Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global genome engineering market to grow with a CAGR of 11.80% over the forecast period of 2018-2024.

The report on global genome engineering market provides qualitative and quantitative analysis for the period of 2016 to 2024. The study on genome engineering market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

A genome is the genetic material of an organism. Genome engineering or genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of the living organism. Several approaches to genome editing have been developed. A recent one is known as CRISPR-Cas9, which is short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. Genome editing is of huge interest in the prevention and treatment of human diseases. Currently, most research on genome engineering is done to understand diseases using cells and animal models.

Rising prevalence of infectious diseases and cancer, and availability of research grants & funding from the government are the primary factors responsible for driving the genome engineering market. Genome engineering is widely used in biotechnology and pharmaceutical companies, these companies are constantly indulged in research and development activities to prepare an antidote for the various infectious disease and cancer that helps to augment market growth. However lack of trained professionals and adverse public perception of genetic research is likely to be the restraint for the market growth.

The use of genetic engineering to treat increasingly prevalent chronic diseases and in preparing specialized or personalized medicine can create huge growth opportunities in near future for genome engineering market.

Geographically, North America is in the leading position among the other regions with a significant market share. U.S drives the North America genome engineering market, on account of factors such as development of gene therapy, increasing use of genetically modified crops and huge government funding for genome engineering research. Europe is expected to grow at the highest CAGR during the forecast period, 2018-2024.

Segments Covered

The global genome engineering market is segmented on the basis of technology, application and end-user.

Global Genome Engineering Market by Technology

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Transcription Activator-like Effector Nuclease (TALEN)
• Zinc Finger Nuclease (ZFN)
• Other Technologies

Global Genome Engineering Market by Application

• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genome Engineering
• Other Applications

Global Genome Engineering Market by End-User

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Company Profiles

• Thermo Fisher Scientific
• Merck
• Horizon Discovery Group
• Genscript
• Sangamo Biosciences
• Integrated DNA Technologies
• Lonza
• New England Biolabs
• Origene Technologies
• Transposagen Biopharmaceuticals
  

For more information about this report visit https://www.researchandmarkets.com/research/stqcg7/global_genome?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets